chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a health professional concerning a 10 year old male pt who was vaccinated on 10/04/2004 with a dose of varicella virus vaccine, live. Subsequently, on approximately 03/12/04, the pt developed breakthrough chickenpox. Follow up information indicated that "there was not a single report of adverse reactions following varicella vaccination". The reporter indicated that 49 other pt's developed breakthrough cases of chickenpox (WAES # 0404USA02615, 0405USA00572, 0405USA00573, 0405USA00574, 0405USA00575, 0405USA00576, 0405USA00577, 0405USA00578, 0405USA00579, 0405USA00580, 0405USA00581, 0405USA00582, 0405USA00583, 0405USA00584, 0405USA00585, 0405USA00586, 0405USA00587, 0405USA00588, 0405USA00589, 0405USA00590, 0405USA00591, 0405USA00592, 0405USA00593, 0405USA00594, 0405USA00595, 0405USA00596, 0405USA00597, 0405USA00598, 0405USA00599, 0405USA00600, 0405USA00601, 0405USA00602, 0405USA00603, 0405USA00604, 0405USA00605, 0405USA00606, 0405USA00607, 0405USA00608, 0405USA00609, 0405USA00610, 0405USA00611, 0405USA00612, 0405USA00613, 0405USA00614, 0405USA00615, 0405USA00616, 0405USA00617, 0405USA00618, 0405USA00619). No further information is expected.
Patient came in with mother and sister requesting flu vaccine. Asked patient mother had she already had flu shot she stated no and that they was coming in for just that. After triaging patient I got gave the form to patients mother to fill out. After signing form injection was given. As  I was documenting that's when I noticed that vaccination had already been given.
This is a 89y.o. female with pmh of hypertension Copd on home o2  esrd on hd, TTS TIA  Gerd/gastric ulcer  Presented to ed with cc of fever and altered mental state,many of her family recently tested positive for covid and with the above symptoms want to check her out that if she has covid,patient is vaccinated for covid. V/s in ed were temp of 100.3 o2 of 98% on 2 lit. Work up in ed shows  Chest xray, elevation of left hemidiaphargm  Ct head -- no acute process K+ this am 6.1 D- dimer  2218 Cbc unremarkable  Bun/cr  51/11.01 Troponin times 3 negative  covid -19 positive When seen patient awake and alert and getting dialyzed,and want to go home,spoke to daughter about the changes she observed at home,that she was mentally altered,according to daughter the responses were slower than normal and staring episode.
CHILLS; MUSCLE ACHE; LOW GRADE FEVER (CONSUMER FEELS WARM); This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included covid-19, and other pre-existing medical conditions included the patient was not pregnant at time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1802070 expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced chills. On 09-MAR-2021, the subject experienced muscle ache. On 09-MAR-2021, the subject experienced low grade fever (consumer feels warm). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from muscle ache, chills, and low grade fever (consumer feels warm). This report was non-serious.
A 51 year old female pt experienced spots before her eyes, faintness, near blindness, and aches pains and tingling in her legs after receiving RabAvert for a stray cat bite. RabAvert was received IM on 13Sep04, 16Sep04, 21Sep04 and 28Sep04. Medical history included high blood pressure and type two diabetes. Concomitant medication included metformin, Toprol XL, Captopril, Risperdal, and Zoloft. A stray cat bit the pt on 11Sep04. On 13Sep04 she received her first injection of RabAvert in her hip and another medication (type unspecified) in the other hip. On 16Sep04 she received her second dose of RabAvert with no adverse events. On 21Sep04 she received her third dose. Immediately after receiving the injections she experienced spots before her eyes and nearly fainted. She also experienced aches, pains and tingling of the legs. The hospital staff had her sit down and the events resolved within 5 minutes without treatment. On 28Sep04 she received her fourth dose and experienced near blindness while driving home from the hospital. She did not stop driving, and the event resolved within 5 minutes with no treatment. She again experienced aches, pains and tingling in her legs, which she treated with oral ibuprofen orally and felt that the events were resolved. She stated she had never experienced any of these events before. Her physician told her that as her white count was fine, she probably has fibromyalgia.
patient came in on Saturday May 15 to let me know her arm was achy and still hurting from the injection.  Advised patient to contact doctor.
Information has been received from a registered nurse concerning a 68 year old female with a history of Shingles who in October 2007, was vaccinated with ZOSTAVAX (Oka/Merck). In April 2008, the patient experienced Shingles outbreak 6 months after she was given ZOSTAVAX (Oka/Merck). The patient recovered from Shingles. The patient sought medical attention. Additional information has been request.
VACCINE ADMINISTERED WAS IN THE FRIDGE MORE THAN 30 DAYS AS  RECOMMENDED BY THE MANUFACTURER.
Information has been received from the authors of the article and refers to a 50 year old male patient. The patient's past medical history included past anaphylaxis, allergies to angiotensin-converting enzyme inhibitors (unspecified), hypertension, and renal cell carcinoma. The patient's concomitant therapies were not reported. On an unknown date, the patient was vaccinated with a dose of pneumococcal polysaccharide vaccine (manufacturer unknown) for prophylaxis (dose number and route were unspecified). Immediately after vaccination, the patient experienced respiratory difficulty, seizure, and cardiorespiratory arrest. Subsequently, the patient died. The cause of death was reported as anaphylactic shock. It was unknown if an autopsy was performed. The authors considered anaphylactic shock to be related to pneumococcal polysaccharide vaccine (manufacturer unknown).
suspected Vaccination failure / Two light flare-ups of shingles spring 2020 / Severe ongoing shingles from nov 28, 2020 to present; Two light flare-ups of shingles spring 2020 / Severe ongoing shingles from nov 28, 2020 to present; This case was reported by a physician and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In 2019, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. In 2020, less than a year after receiving Shingrix and Shingrix and an unknown time after starting Valacyclovir, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The patient was treated with valaciclovir hydrochloride (Valacyclovir). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: Age group was captured as adult as per vaccine indication. Age at vaccination was not reported. After taking both shingrix doses in late 2019, then the patient had two light flare ups of shingles in spring 2020, then severe ongoing shingles from 28th November 2020 to 31st March, 2021.  The patient also wonder if the patient could get the high cost of the two shingrix doses refund by the company. The patient have had to take high doses of valacyclovir to treat this severe during this time period also received two covid vaccines.  The patient asked would there be an interference in the effective of the covid vaccine by valacyclovir. This case was considered as suspected vaccination failure as details regarding vaccination schedule, time to onset for target disease and laboratory confirmation were unknown at the time of reporting.
Hives, lip swelling, ear swelling, swelling of hands and feet. RX with epinephrine and IM dexamethasone and oral steroid, benadryl, hydroxyzine, pepsid,
Debilitating elbow pain/ joint pain In left elbow that has not subsided/elbow pain/ Following covid vax in left arm arthritis type pain developed in 24 hrs and has been persistant; Debilitating elbow pain/ joint pain In left elbow that has not subsided/elbow pain/ Following covid vax in left arm arthritis type pain developed in 24 hrs and has been persistant; This is a spontaneous report from a contactable other Health Care Professional (patient). A 42-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: Ep6955), via an unspecified route of administration in left arm on 27Mar2021 12:00 as (at the age of 42 years old, not pregnant at the time of vaccination) dose 1, single for covid-19 immunisation. Medical history included covid prior vaccination. The patient had no known allergies. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 28Mar2021 patient experienced debilitating elbow pain/ joint pain In left elbow that has not subsided. Following covid vaccine in left arm arthritis type pain developed in 24 hours and has been persistent. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: ER8731), via an unspecified route of administration in left arm on 17Apr2021 at 12:00 for covid-19 immunization. No relevant tests were performed. The patient did not received treatment due to the events. No hospitalization required. Reporter considered events as non-serious. The outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected.
Patient had Infanrix vaccine on 6/21 and she was running low grade temps 101 for the next 3 days on 6/23 in evening she was not acting normal and suddenly became limp, eyes rolled back in head. EMS was called and she was taken to the ER where she had a 102 temp. No other s/s of illness. UA was done in ER and norm
Bilateral DVT and pulmonary embolism 1 month later, on 5/8/2021
rash that started on back of both arms, then hands and now feet and legs; kind of itchy; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: EN6208, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 12Mar2021 09:45 (at the age of 51-years-old) as unknown, single dose for COVID-19 immunisation. Medical history included high blood pressure, cholesterol and acute pancreatitis all from an unknown date. The patient previously took metronidazole (FLAGYL) and experienced allergies from an unknown date. Concomitant medications included losartan and sulfamethoxazole, trimethoprim both taken for an unspecified indication, start and stop date were not reported. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination, the patient has not been diagnosed with COVID-19. On 13Mar2021 11:00, the patient experienced rash that started on back of both arms, then hands and now feet and legs and kind of itchy. It was unknown if treatment was received for the events. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was unknown.   No follow-up attempts are possible. No further information expected.
Hard Lump; Redness; Itching; Hot to touch; Lasted a couple of days
It began with sneezing it went on for a long time then for a few days I had nasal congestion sore throat and fatigue, then after several days I began to cough and had lung congestion. On the fourth day I had symptoms I began to take zinc and took it until my symptoms resolved. The main symptoms went away after one week but nasal congestion continued for another week. A home COVID-19 test on 15FEB2023 was positive.
Patient feels like got run over with a truck and back over again; Patient has a fever of 102.8 F; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Patient feels like got run over with a truck and back over again) and PYREXIA (Patient has a fever of 102.8 F) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient previously had COVID) and Pneumonia (Patient previously had COVID and was hospitalized with pneumonia).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Patient feels like got run over with a truck and back over again) and PYREXIA (Patient has a fever of 102.8 F). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event following immunisation, at a dose of 2 dosage form. At the time of the report, MALAISE (Patient feels like got run over with a truck and back over again) and PYREXIA (Patient has a fever of 102.8 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 102.8 f (High) fever of 102.8 F..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Around 6:30 tonight I realized I was feeling hot, so I took my temperature; it registered 100.8. I hardly ever run a temperature even when sick. All day I'd been feeling a little tired, but it was worse this evening. The injection site was very sore and only slightly red. No throat or sinus involvement; taste and smell unaffected. Mild headache with mild intermittent aching in left eye socket.
fever, chills, nausea, joint pain, headache. diarrhea started over night (approx 9-10 hours after injection) started to subside 24 hours after injection, or at least I was able to get out of bed and eat something at that time.
diarrhea, mild fever, headache.  patient typically runs around 97.6 and was at a 98.9 a few days after vaccination. also had mild diarrhea and a headache (taking APAP)
FATIGUE; SHAKINESS IN ARMS AND LEGS; WEAKNESS IN ARMS AND LEGS; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced shakiness in arms and legs. On APR-2021, the subject experienced weakness in arms and legs. On an unspecified date, the subject experienced fatigue. Laboratory data (dates unspecified) included: Thyroid function test (NR: not provided) ELEVATED. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shakiness in arms and legs, and weakness in arms and legs, and the outcome of fatigue was not reported. This report was non-serious.
CANNOT SWALLOW PROPERLY; FEELING PAIN IN LEFT ARM; PAIN AT INJECTION SITE; NAUSEA; MUSCLE PAIN; HEADACHE; BLURRY VISION; HOT FEELING SENSATION; DIZZINESS; SWEATING; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included heart test was performed. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980 expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 16:00 for prophylactic vaccination. No concomitant medications were reported.  On 2021, Laboratory data included: X-ray (NR: not provided) Not reported. On 30-MAR-2021 16:30, the subject experienced hot feeling sensation. On 30-MAR-2021 16:30, the subject experienced dizziness. On 30-MAR-2021 16:30, the subject experienced sweating. On 31-MAR-2021, the subject experienced blurry vision. On 31-MAR-2021, the subject experienced feeling pain in left arm. On 31-MAR-2021, the subject experienced pain at injection site. On 31-MAR-2021, the subject experienced nausea. On 31-MAR-2021, the subject experienced muscle pain. On 31-MAR-2021, the subject experienced headache. On 04-APR-2021, the subject experienced cannot swallow properly. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from hot feeling sensation, and sweating on 31-MAR-2021, was recovering from pain at injection site, had not recovered from dizziness, nausea, muscle pain, headache, blurry vision, and cannot swallow properly, and the outcome of feeling pain in left arm was not reported. This report was non-serious.
Pt received Pfizer x2.  Pt tested COVID + on 9/13/21 and admitted to hospital for COVID on 9/27/2021. Pt received remdesivir and dexamethasone.
Elevated heart rate, palpatations, light headedness, headache, feverish, nausea.
Patient was inadvertently given bivalent version rather than monovalent version for first dose in the primary series. No adverse reactions or other problems reported.
Respiratory Reaction evident a few hours after the flu shot was administered.  I received a shot around noon and by the early afternoon I was experiencing wheezing symptoms and difficulty breathing.  This lasted through the evening, but did not require hospitalization, nor was treatment sought.  By the morning I was back to normal.  However, I have had repeated wheezing episodes ever since, which have progressively grown worse.  I have sought advice from my primary doctor and a specialist who now inform me I have asthma with no prior symptoms or episodes prior to the flu vaccine.
Pt. is having numbness on her left arm which made it difficult for her to lift or move it. Pt. was advised by Primary Care Physician to see a neurologist to determine at the same time of a nerve was hit when the shot was done - per patient.
15 hrs after received my second shot, I had a fever of 102 and chills and the fever continued through the night and its 100 in the morning. took tylenol. Had no reaction post first vaccine
This spontaneous report was received from a male patient of unknown age, who was reporting on himself. On an unknown date in approximately 2015 (reported as "about two years ago"), the patient was vaccinated with ZOSTAVAX, subcutaneous injection for herpes zoster. On 23-AUG-2017, the patient experienced skin disorder and pruritus. The patient applied cortisone to treat the events. The patient did not seek medical attention yet, but had scheduled an appointment with his physician on 24-AUG-2017. The outcome of the events was reported as not recovered/not resolved at the time of this report. The relatedness between the events and ZOSTAVAX was not assessed by the reporter. Product quality complaint was not involved.
Coughing, wheezing, hives, throat tightening. Treated with benadryl 25mg and symptoms lessened in about 30 minutes.
Dizziness several hours after shot, has been on and off for several day; last night nausea and fever; last night nausea and fever; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 07May2021 at 13:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The medical history included high blood pressure, thyroid issues and allergy to gluten. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 16Apr2021 at 18:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. On an unknown date in 2021, several hours after the vaccination, the patient experienced dizziness which had been on and off for several days and last night from the day of report the patient also had nausea and fever. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizziness, nausea and fever were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
flu-like symptoms with fever after second covid vaccine; flu-like symptoms with fever after second covid vaccine; platelet count was low; platelet count was low and some had change in shape; This is a spontaneous report from a contactable reporter reported and a consumer. A 45-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 31Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunization.  Medical history included breast cancer. The patient's concomitant medications were not reported.  The patient experienced flu-like symptoms with fever after second covid vaccine on an unspecified date.  The patient had to delay palbociclib start 5 days. The patient will have lab work in 2 weeks. MD said platelet count was low and some had change in shape, not sure if due to the vaccine or the medication (palbociclib). The outcome of the events was unknown. Information on the lot/batch number has been requested.
Patient is only 17 years old and Moderna is only approved for patients 18 years old and older.
pt recvd vax;sxs started eve of vax;lt arm where pneumonia shot given,red,warm,swollen;sx got worse & to MD;rx keflex x 2 days;arm infect at inject; dx per MD; lt arm swollen above & below elbow;2nd PMD visit 18noov94;arm better;